Molecular diagnostics company Qvella hauls in $20 mln Series B
Qvella, a Canadian molecular diagnostics company, has secured $20 million in Series B financing. The investors included RA Capital, Whitecap Venture Partners, Hatteras Ventures, Sands Capital and bioMérieux.
4 December 2017•1 min read
